Amgen is undeterred by investors’ skepticism and is pushing forward aggressively with a broad phase 3 program that includes ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ('Tiziana” or the 'Company”), today announces it will advance its second asset, a fully human anti-IL-6 receptor ('IL-6R”) monoclonal antibody, TZLS-501.
Public employees in a northern Manitoba First Nation have been given mandatory drug tests, which the community's chief says ...
President Donald Trump spent several days promising Americans that “an answer to autism” was imminent. Instead, his big ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced positive topline results from the US Phase 3 ConfIdeS trial of imlifidase, evaluating 12-month kidney function ...
Detailed price information for Cg Oncology Inc (CGON-Q) from The Globe and Mail including charting and trades.
Bernstein 2nd Annual Global Healthcare Conference September 24, 2025 11:20 AM EDTCompany ParticipantsPriya Singhal - Executive ...
Alabama donations featured during Hunger Action Month In recognition of Hunger Action Month in, Dollar General is ...
Edmonton Journal on MSNOpinion
Lorne Gunter: Liberal gun buyback a political ploy that won't impact crime
Federal Public Safety Minister Gary Anandasangaree was recorded on Sunday, during a private conversation with a longtime ...
Opinion
4hOpinion
As the first Millennial women enter perimenopause, advances in hormone therapy show promise
But time comes for us al―and for us Millennials―that means contending with the gentle ebb of collagen, youthful hormone production, and its impact on our daily lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback